Characterisation of patients with familial chylomicronaemia syndrome (FCS) and multifactorial chylomicronaemia syndrome (MCS): Establishment of an FCS clinical diagnostic score

Autor: Philippe Moulin, Robert Dufour, Maurizio Averna, Marcello Arca, Angelo B. Cefalù, Davide Noto, Laura D’Erasmo, Alessia Di Costanzo, Christophe Marçais, Luis Antonio Alvarez-Sala Walther, Maciej Banach, Jan Borén, Robert Cramb, Ioanna Gouni-Berthold, Elizabeth Hughes, Colin Johnson, Xavier Pintó, Željko Reiner, Jeanine Roeters van Lennep, Handrean Soran, Claudia Stefanutti, Erik Stroes, Eric Bruckert

Publikováno v: Data in Brief, Vol 21, Iss , Pp 1334-1336 (2018)

Data presented in this article are supplementary material to our article entitled “Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): expert panel recommendations and proposal of an “FCS Score” (Moulin et al

Externí odkaz: https://doaj.org/article/e3151c823e6a4206b9afc2f7a8d0b1f8

Garadacimab, a Factor XIIa Inhibitor for Hereditary Angioedema Prevention (VANGUARD Study)

Autor: Timothy Craig, Avner Reshef, Huamin Henry Li, Joshua S. Jacobs, Jonathan A. Bernstein, Henriette Farkas, William H. Yang, Erik Stroes, Isao Ohsawa, Raffi Tachdjian, Michael E. Manning, William R. Lumry, Inmaculada Martinez Saguer, Emel Aygören-Pürsün, Bruce Ritchie, Gordon L. Sussman, John Anderson, Kimito Kawahata, Yusuke Suzuki, Petra Staubach, Regina Treudler, Henrike Feuersenger, Fiona Glassman, Iris Jacobs, Markus Magerl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::08ef1a615b3d0e2b213435ca175bf48e
https://doi.org/10.2139/ssrn.4336148

Evinacumab for Homozygous Familial Hypercholesterolemia

Autor: Gerald Watts, Farrah Deeba, David Sullivan, Paul Donald Bonnitcha, San San Min, Nimalie Jacintha Nanayakkara, Christopher Ebenbichler, Alexander Tschoner, Clemens Engler, Daniel Gaudet, Nathalie Roy, David Blackburn, Jean Bergeron, Hisee Villeneuve, Samir Saheb, Antonio Gallo, Sophia Beliard, Bertrand Dussol, Sophie Morange, Pascale Poullin, Rene Valero, Charalampos Milionis, Sebastian Filippas-Ntekouan, Eleftherios Klouras, Genovefa Kolovou, George Hatzigeorgiou, Spyridon Rammos, Paolo Rubba, Gabriella Iannuzzo, Mariko Harada-Shiba, Cheol Son, Hisashi Makino, Kiminori Hosoda, Kota Matsuki, Kyoko Kohmo, Masaki Matsubara, Masatsune Ogura, Michio Noguchio, Miki Matsuo, Ryo Koezuka, Tamiko Tamanaha, Tsutomu Tomita, Yoko Ohata, Yoshihiko Otsubo, Noriaki Koyanagi, Masaaki Kawashiri, Hayato Tada, Atsushi Nohara, Akihiro Nomura, Hirofumi Okada, Naohiko Fujii, Daisuke Hayashi, Sayoko Yonemoto, Shungo Fukuda, Koji Yanagi, Miwa Ryo, Masahiro Koseki, Makoto Nishida, Takeshi Okada, Erik Stroes, Laurens Reeskamp, Daniela Stols-Goncalves, Eva Hamulyak, Anho H Liem, Jurgen M Akkerhuis, Pieter R Nierop, Bastiaan M van Dalen, Sweder W E van de Poll, Adriana J M van Miltenburg-van Zijl, Marinus J Veerhoek, Frederick Raal, Sindeep Amrat Bhana, Olena Mitchenko, Vadym Romanov, Iryna Chulaevska, Leonid Rudenko, Olena Beregova, Igor Vakaliuk, Iryna Drapchak, Natalia Tymochko, Anna Isayeva, Olena Buriakovska, Maryna Vovchenko, Vira Tseluyko, Nataliya Matviychuk, Larysa Yakovleva, Paul Duell, Jonathan Barton Purnell, Robert Rosenson, Donald Smith, Theresa Halloran, Robert Gottlieb, Peter A McCullough, Zachary P Rosol, Andy Y Lee, Clay M Barbin, Seth J Baum, Reina Mendelson, Melissa Wright, Linda Hemphill, Akl Fahed, Traci Turner, Angela Ellard

Publikováno v: New England journal of medicine, 383(8), 711-720. Massachussetts Medical Society

BACKGROUND: Homozygous familial hypercholesterolemia is characterized by premature cardiovascular disease caused by markedly elevated levels of low-density lipoprotein (LDL) cholesterol. This disorder is associated with genetic variants that result i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb713acb8c8c2d3fe0124031a30d496a
https://doi.org/10.1056/nejmoa2004215

The effect of a diiodothyronine mimetic on insulin sensitivity in male cardiometabolic patients: a double-blind randomized controlled trial.

Autor: Fleur van der Valk, Carlijne Hassing, Maartje Visser, Purav Thakkar, Anookh Mohanan, Kaushal Pathak, Chaitanya Dutt, Vijay Chauthaiwale, Mariette Ackermans, Aart Nederveen, Mireille Serlie, Max Nieuwdorp, Erik Stroes

Publikováno v: PLoS ONE, Vol 9, Iss 2, p e86890 (2014)

BACKGROUND AND AIMS:Obesity and its associated cardiometabolic co-morbidities are increasing worldwide. Since thyroid hormone mimetics are capable of uncoupling the beneficial metabolic effects of thyroid hormones from their deleterious effects on he

Externí odkaz: https://doaj.org/article/1813bd211091417ab7237a0398d0b8fe

Nevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral-therapy-naive patients infected with HIV-1.

Autor: Frank van Leth, Prahpan Phanuphak, Erik Stroes, Brian Gazzard, Pedro Cahn, François Raffi, Robin Wood, Mark Bloch, Christine Katlama, John J P Kastelein, Mauro Schechter, Robert L Murphy, Andrzej Horban, David B Hall, Joep M A Lange, Peter Reiss

Publikováno v: PLoS Medicine, Vol 1, Iss 1, p e19 (2004)

BACKGROUND: Patients infected with HIV-1 initiating antiretroviral therapy (ART) containing a non-nucleoside reverse transcriptase inhibitor (NNRTI) show presumably fewer atherogenic lipid changes than those initiating most ARTs containing a protease

Externí odkaz: https://doaj.org/article/a95b0734c7444610b52edecb6cabb9c6